Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7130-7144

  Iba, Yoshitaka ^a   Fujii, Yoshifumi ^b   Ohshima, Nobuko ^a   Sumida, Tomomi ^b   Kubota Koketsu, Ritsuko ^c   Ikeda, Mariko ^b   Wakiyama, Motoaki ^b   Shirouzu, Mikako ^b   Okada, Jun ^d   Okuno, Yoshinobu ^e   Kurosawa, Yoshikazu ^a   Yokoyama, Shigeyuki ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Medical & Biological Laboratories Co Ltd   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; F005 126 FAB ANTIBODY; GLYCAN; INFLUENZA VIRUS HEMAGGLUTININ; UNCLASSIFIED DRUG; VIRUS ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; CROSS LINKING; CRYSTAL STRUCTURE; DEGLYCOSYLATION; HYDROGEN BOND; INFLUENZA VIRUS A H3N2; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS NEUTRALIZATION; CHEMISTRY; DRUG EFFECTS; EPITOPE MAPPING; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; VIROLOGY;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BASE SEQUENCE; EPITOPE MAPPING; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84901981487     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00420-14     Document Type: Article

References (60)

1. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
2. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378. http://dx.doi .org/10.1038/289373a0.
3. Underwood PA. 1982. Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. J. Gen. Virol. 62:153-169. http://dx.doi.org/10.1099 /0022-1317-62-1-153.
4. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417-427. http://dx.doi.org/10.1016/0092-8674(82)90135-0.
5. Salzberg S. 2008. The contents of the syringe. Nature 454:160-161. http: //dx.doi.org/10.1038/454160a.
6. Okuno Y, Isegawa Y, Sasao F, Ueda S. 1993. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67:2552-2558.
7. Smirnov YA, Lipatov AS, Gitelman AK, Okuno Y, Van Beek R, Osterhaus AD, Claas EC. 1999. An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Acta Virol. 43:237-244.
8. Dreyfus C, Ekiert DC, Wilson IA. 2013. Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin. J. Virol. 87:7149-7154. http://dx.doi.org/10.1128 /JVI.02975-12.
9. Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, Horowitz L, Palese P, Bhatt RR, Lerner RA. 2008. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc. Natl. Acad. Sci. U. S. A. 105:5986-5991. http://dx.doi.org /10.1073/pnas.0801367105.
10. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3:e3942. http://dx.doi.org/10.1371/journal.pone.0003942.
11. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273. http://dx.doi.org/10.1038/nsmb.1566.
12. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251. http://dx.doi.org /10.1126/science.1171491.
13. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J. 2011. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850. http://dx.doi.org/10 .1126/science.1204839.
14. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856. http://dx.doi.org/10.1126/science.1205669.
15. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, Ekiert DC, Lee JH, Metlagel Z, Bujny MV, Jongeneelen M, van der Vlugt R, Lamrani M, Korse HJ, Geelen E, Sahin Ö Sieuwerts M, Brakenhoff JP, Vogels R, Li OT, Poon LL, Peiris M, Koudstaal W, Ward AB, Wilson IA, Goudsmit J, Friesen RH. 2012. Highly conserved protective epitopes on influenza B viruses. Science 337:1343-1348. http://dx.doi.org/10.1126 /science.1222908.
16. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao HX, Harrison SC. 2011. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. U. S. A. 108:14216-14221. http://dx.doi.org/10.1073 /pnas.1111497108.
17. Schmidt AG, Xu H, Khan AR, O'Donnell T, Khurana S, King LR, Manischewitz J, Golding H, Suphaphiphat P, Carfi A, Settembre EC, Dormitzer PR, Kepler TB, Zhang R, Moody MA, Haynes BF, Liao HX, Shaw DE, Harrison SC. 2013. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc. Natl. Acad. Sci. U. S. A. 110:264-269. http://dx.doi.org/10 .1073/pnas.1218256109.
18. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, Lee JH, Dillon MA, O'Neil RE, Faynboym AM, Horowitz M, Horowitz L, Ward AB, Palese P, Webby R, Lerner RA, Bhatt RR, Wilson IA. 2012. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489:526-532. http://dx.doi.org/10.1038/nature11414.
19. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE, Jr. 2011. A broadly neutralizing monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85:10905-10908. http://dx.doi.org/10.1128/JVI .00700-11.
20. Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE, Jr, Ward AB, Wilson IA. 2013. Antibody recognition of the pandemic H1N1 influenza hemagglutinin receptor binding site. J. Virol. 87:12471-12480. http://dx.doi.org/10.1128/JVI .01388-13.
21. Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, Ito K, Takada A. 2009. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog. 3:e1000350. http://dx.doi.org/10.1371 /journal.ppat.1000350.
22. Lee PS, Yoshida R, Ekiert DC, Sakai N, Suzuki Y, Takada A, Wilson IA. 2012. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc. Natl. Acad. Sci. U. S. A. 109:17040-17045. http://dx.doi.org/10.1073/pnas.1212371109.
23. Xu R, Krause JC, McBride R, Paulson JC, Crowe JE, Jr, Wilson IA. 2013. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat. Struct. Mol. Biol. 20:363-370. http: //dx.doi.org/10.1038/nsmb.2500.
24. Ohshima N, Iba Y, Kubota-Koketsu R, Asano Y, Okuno Y, Kurosawa Y. 2011. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J. Virol. 85:11048-11057. http://dx.doi.org/10.1128/JVI.05397-11.
25. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. 1991. By-passing immunization. Human antibodies from Vgene libraries displayed on phage. J. Mol. Biol. 222:581-597.
26. Iba Y, Ito W, Kurosawa Y. 1997. Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody. Gene 194:35-46. http://dx.doi.org/10.1016/S0378-1119(97)00101-7.
27. Morino K, Katsumi H, Akahori Y, Iba Y, Shinohara M, Ukai Y, Kohara Y, Kurosawa Y. 2001. Antibody fusions with fluorescent proteins: a versatile regent for profiling protein expression. J. Immunol. Methods 257: 175-184. http://dx.doi.org/10.1016/S0022-1759(01)00462-8.
28. Abhinandan KR, Martin AC. 2008. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol. Immunol. 45:3832-3839. http://dx.doi.org/10.1016/j.molimm.2008.05 .022.
29. Ito W, Kurosawa Y. 1993. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J. Biol. Chem. 268:20668-20675.
30. Higo-Moriguchi K, Akahori Y, Iba Y, Kurosawa Y, Taniguchi K. 2004. Isolation of human monoclonal antibodies that neutralize human rotavirus. J. Virol. 78:3325-3332. http://dx.doi.org/10.1128/JVI.78.7.3325-3332 .2004.
31. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, Ueda S. 1990. Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J. Clin. Microbiol. 28:1308-1313.
32. Nakagawa N, Kubota R, Nakagawa T, Okuno Y. 2001. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains. J. Gen. Virol. 82:2169-2172.
33. Ueda M, Maeda A, Nakagawa N, Kase T, Kubota R, Takamura H, Ohshima A, Okuno Y. 1998. Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J. Clin. Microbiol. 36:340-344.
34. Okada J, Ohshima N, Kubota-Koketsu R, Ota S, Takase W, Azuma M, Iba Y, Nakagawa N, Yoshikawa T, Nakajima Y, Ishikawa T, Asano Y, Okuno Y, Kurosawa Y. 2010. Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified in to three groups with distinct strain specificity: 1968-1973, 1977-1993 and 1997-2003. Virology 397:322-330. http://dx.doi.org/10.1016/j.virol.2009.11.025.
35. Okada J, Ohshima N, Kubota-Koketsu R, Iba Y, Ota S, Takase W, Yoshikawa T, Ishikawa T, Asano Y, Okuno Y, Kurosawa Y. 2011. Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. J. Gen. Virol. 92:326-335. http://dx.doi.org/10.1099/vir.0.026419-0.
36. Kabsch W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Cryst. 26:795-800. http://dx.doi.org/10.1107/S0021889893005588.
37. Otwinowski ZO, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326. http://dx .doi.org/10.1016/S0076-6879(97)76066-X.
38. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. 1988. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95:409-417.
39. Fleury D, Daniels RS, Skehel JJ, Knossow M, Bizebard T. 2000. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins 40:572-578. http://dx.doi.org/10.1002/1097-0134 (20000901)40:4<572::AID-PROT30>3.0.CO;2-N.
40. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. http://dx .doi.org/10.1107/S0907444904019158.
41. Terwilliger TC. 2000. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56:965-972. http://dx.doi.org/10.1107 /S0907444900005072.
42. Terwilliger TC. 2002. Statistical density modification with noncrystallographic symmetry. Acta Crystallogr.DBiol. Crystallogr. 58:2082-2086. http://dx.doi.org/10.1107/S0907444902016360.
43. Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66:12-21. http://dx.doi.org/10.1107 /S1744309109042018.
44. Connolly ML. 1983. Solvent-accessible surfaces of proteins and nucleic acids. J. Appl. Crystallogr. 221:709-713.
45. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70-74. http://dx.doi.org/10.1006 /viro.2001.1320.
46. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289: 366-373. http://dx.doi.org/10.1038/289366a0.
47. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, Wiley DC. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 79:968-972. http://dx.doi.org/10 .1073/pnas.79.4.968.
48. Gallagher PJ, Henneberry JM, Sambrook JF, Gething MJ. 1992. Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus. J. Virol. 66:7136-7145.
49. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Jr, Wilson IA. 2010. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328:357-360. http://dx.doi.org/10.1126/science .1186430.
50. Fleury D, Barrère B, Bizebard T, Daniels RS, Skehel JJ, Knossow M.1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6:530-534. http://dx.doi.org/10.1038/9299.
51. Knossow M, Gaudier M, Douglas A, Barrère B, Bizebard T, Barbey C, Gigant B, Skehel JJ. 2002. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302:294-298. http://dx.doi.org/10 .1006/viro.2002.1625.
52. Daniels PS, Jeffries S, Yates P, Schild GC, Rogers GN, Paulson JC, Wharton SA, Douglas AR, Skehel JJ, Wiley DC. 1987. The receptorbinding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J. 6:1459-1465.
53. Carr CM, Kim PS. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832. http://dx.doi .org/10.1016/0092-8674(93)90260-W.
54. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43. http://dx.doi.org/10.1038/371037a0.
55. Carr CM, Chaudhry C, Kim PS. 1997. Influenza hemagglutinin is springloaded by a metastable native conformation. Proc. Natl. Acad. Sci. U. S. A. 94:14306-14313. http://dx.doi.org/10.1073/pnas.94.26.14306.
56. Xu R, Wilson IA. 2011. Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J. Virol. 85:5172-5182. http://dx.doi.org/10.1128/JVI.02430-10.
57. Rachakonda PS, Veit M, Korte T, Ludwig K, Böttcher C, Huang Q, Schmidt MF, Herrmann A. 2007. The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J. 21:995-1002. http: //dx.doi.org/10.1096/fj.06-7052hyp.
58. Huang Q, Opitz R, Knapp EW, Herrmann A. 2002. Protonation and stability of the globular domain of influenza virus hemagglutinin. Biophys. J. 82:1050-1058. http://dx.doi.org/10.1016/S0006-3495(02)75464-7.
59. Zhu X, Guo YH, Jiang T, Wang YD, Chan KH, Li XF, Yu W, McBride R, Paulson JC, Yuen KY, Qin CF, Che XY, Wilson IA. 2013. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by a murine antibody against the A/goose/Guangdong/1/96 hemagglutinin. J. Virol. 87:12619-12635. http://dx.doi.org/10.1128/JVI.01577-13.
60. Karplus PA, Diederichs K. 2012. Linking crystallographic model and data quality. Science 336:1030-1033. http://dx.doi.org/10.1126/science .1218231.